GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » Price-to-Owner-Earnings

Dis-Chem Pharmacies (JSE:DCP) Price-to-Owner-Earnings : 28.76 (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies Price-to-Owner-Earnings?

As of today (2024-05-15), Dis-Chem Pharmacies's share price is R33.65. Dis-Chem Pharmacies's Owner Earnings per Share (TTM) ended in Feb. 2023 was R1.17. It's Price-to-Owner-Earnings for today is 28.76.


The historical rank and industry rank for Dis-Chem Pharmacies's Price-to-Owner-Earnings or its related term are showing as below:

JSE:DCP' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.54   Med: 25.06   Max: 62.56
Current: 28.5

During the past 10 years, the highest Price-to-Owner-Earnings of Dis-Chem Pharmacies was 62.56. The lowest was 10.54. And the median was 25.06.


JSE:DCP's Price-to-Owner-Earnings is ranked worse than
60.53% of 266 companies
in the Healthcare Providers & Services industry
Industry Median: 20.675 vs JSE:DCP: 28.50

As of today (2024-05-15), Dis-Chem Pharmacies's share price is R33.65. Dis-Chem Pharmacies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was R1.05. Therefore, Dis-Chem Pharmacies's PE Ratio for today is 32.20.

As of today (2024-05-15), Dis-Chem Pharmacies's share price is R33.65. Dis-Chem Pharmacies's EPS without NRI for the trailing twelve months (TTM) ended in was R1.04. Therefore, Dis-Chem Pharmacies's PE Ratio without NRI for today is 32.23.

During the past 10 years, Dis-Chem Pharmacies's highest PE Ratio without NRI was 54.91. The lowest was 10.10. And the median was 31.92.


Dis-Chem Pharmacies Price-to-Owner-Earnings Historical Data

The historical data trend for Dis-Chem Pharmacies's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies Price-to-Owner-Earnings Chart

Dis-Chem Pharmacies Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.23 13.59 19.86 18.39 23.16

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 18.39 - 23.16 -

Competitive Comparison of Dis-Chem Pharmacies's Price-to-Owner-Earnings

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's Price-to-Owner-Earnings falls into.



Dis-Chem Pharmacies Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Dis-Chem Pharmacies's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=33.65/1.17
=28.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies  (JSE:DCP) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Dis-Chem Pharmacies Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.